TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2007: $13.86B2008: $16.44B2009: $19.26B2010: $22.00B2011: $22.34B2012: $22.87B2013: $22.64B2016: $34.99B2017: $18.75B2018: $15.79B2019: $15.06B2020: $11.06B2021: $11.24B2022: $8.60B2023: $8.13B2024: $5.38B2025: $7.91B$7.91B
2007Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$7.91B+47.1%
2024$5.38B-33.8%
2023$8.13B-5.5%
2022$8.60B-23.5%
2021$11.24B+1.7%
2020$11.06B-26.6%
2019$15.06B-4.6%
2018$15.79B-15.7%
2017$18.75B-46.4%
2016$34.99B
2013$22.64B-1.0%
2012$22.87B+2.3%
2011$22.34B+1.5%
2010$22.00B+14.2%
2009$19.26B+17.2%
2008$16.44B+18.6%
2007$13.86B